GENERATION HEALTH – Trademark Portfolio
Entity Type: 03
GENERATION HEALTH holds 40 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 27 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include CORDY MAX, PHARMANEX, and TEGREEN 97. The owner is based in Calabasas, CA.
26500 West Agoura Road, Suite 210
Calabasas, CA 913021952
Showing of trademarks Trademarks
Trademark Classifications
GENERATION HEALTH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does GENERATION HEALTH have?
GENERATION HEALTH has 40 U.S. trademarks filed with the USPTO. Of these, 5 registered, 31 abandoned, 4 cancelled.
What trademark classes does GENERATION HEALTH file in?
GENERATION HEALTH files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GENERATION HEALTH's most well-known trademarks?
GENERATION HEALTH's registered trademark portfolio includes well-known marks such as CORDY MAX, PHARMANEX, and TEGREEN 97. These are among 5 currently registered trademarks in the portfolio.
What is GENERATION HEALTH's trademark registration success rate?
GENERATION HEALTH has a 13% trademark registration rate, with 5 out of 40 resolved applications resulting in successful registration. Currently, 0 applications are pending review.